[PDF][PDF] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …
JAC Sterne, PN Bodalia, PA Bryden, PA Davies… - scholar.archive.org
Jonathan AC Sterne, 1* Pritesh N Bodalia, 2, 3 Peter A Bryden, 1 Philippa A Davies, 1 Jose
A López-López, 1 George N Okoli, 1 Howard HZ Thom, 1 Deborah M Caldwell, 1 Sofia Dias …
A López-López, 1 George N Okoli, 1 Howard HZ Thom, 1 Deborah M Caldwell, 1 Sofia Dias …
[HTML][HTML] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …
JAC Sterne, PN Bodalia, PA Bryden, PA Davies… - 2017 - ncbi.nlm.nih.gov
Background: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …
[PDF][PDF] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …
JAC Sterne, PN Bodalia, PA Bryden, PA Davies… - core.ac.uk
Jonathan AC Sterne, 1* Pritesh N Bodalia, 2, 3 Peter A Bryden, 1 Philippa A Davies, 1 Jose
A López-López, 1 George N Okoli, 1 Howard HZ Thom, 1 Deborah M Caldwell, 1 Sofia Dias …
A López-López, 1 George N Okoli, 1 Howard HZ Thom, 1 Deborah M Caldwell, 1 Sofia Dias …
[PDF][PDF] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …
JAC Sterne, PN Bodalia, PA Bryden, PA Davies… - research-information.bris.ac.uk
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous
thromboembolic disease, and for prevent Page 1 Sterne, JA, Bodalia, PN, Bryden, PA, Davies …
thromboembolic disease, and for prevent Page 1 Sterne, JA, Bodalia, PN, Bryden, PA, Davies …
[PDF][PDF] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …
JAC Sterne, PN Bodalia, PA Bryden, PA Davies… - eprints.whiterose.ac.uk
Jonathan AC Sterne, 1* Pritesh N Bodalia, 2, 3 Peter A Bryden, 1 Philippa A Davies, 1 Jose
A López-López, 1 George N Okoli, 1 Howard HZ Thom, 1 Deborah M Caldwell, 1 Sofia Dias …
A López-López, 1 George N Okoli, 1 Howard HZ Thom, 1 Deborah M Caldwell, 1 Sofia Dias …
Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation …
JA Sterne, PN Bodalia, PA Bryden… - Health Technology …, 2017 - ncbi.nlm.nih.gov
BACKGROUND Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …
[HTML][HTML] Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial …
JA Sterne, PN Bodalia, PA Bryden… - Health Technology …, 2017 - europepmc.org
Background Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …